Regadenoson Injection, Solution
Product Images NDC 68083-175

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 68083-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson-spl-carton (Regadenoson Spl Carton)

The packaging label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) solution for intravenous use. It is labeled as a pharmacologic stress agent for diagnostic purposes only. The package contains 10 sterile vials of 5 mL single-dose each, manufactured by Gland Pharma Limited, India. The NDC on the label is 68083-175-10 and the label includes storage instructions and ingredients information.*

FDA Label Image

Regadenoson-spl-structure (Regadenoson Spl Structure)

Chemical structure diagram of Regadenoson showing its molecular components, including a sugar moiety and heterocyclic rings, with a notation for the presence of one water molecule (hydrate).*

FDA Label Image

Regadenoson-spl-vial (Regadenoson Spl Vial)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) solution for intravenous use. The 5 mL single-dose vial is sterile and intended as a pharmacologic stress agent for diagnostic purposes. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions specify 20° to 25°C (68° to 77°F), with reference to USP Controlled Room Temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.